October 19, 2015 / 12:51 PM / 3 years ago

Valeant CEO sees new drug pricing environment ahead

NEW YORK, Oct 19 (Reuters) - Valeant Pharmaceuticals International Inc CEO J. Michael Pearson said on Monday that outside pressures are creating a new pricing environment for all pharmaceutical companies and that Valeant expects to keep increases to 10 percent or less next year.

During a conference call with investors in which he defended the company’s drug pricing strategy, Pearson said that Valeant has begun during the past two years to increase sales volumes as a percentage of growth compared with price increases.

Reporting by Caroline Humer

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below